|
|
|
|
| LEADER |
01810nam a2200337 u 4500 |
| 001 |
EB001897129 |
| 003 |
EBX01000000000000001060134 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
200523 r ||| eng |
| 100 |
1 |
|
|a Young, Calvin
|
| 245 |
0 |
0 |
|a N-Acetylcysteine instillation during bronchoscopy for patients requiring non-cystic fibrosis-related mucus secretion clearance
|h Elektronische Ressource
|b a review of clinical effectiveness and guidelines
|c Calvin Young, Suzanne McCormack
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa
|b CADTH
|c 2019, August 02, 2019
|
| 300 |
|
|
|a 1 PDF file (8 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Bronchoscopy
|
| 653 |
|
|
|a Expectorants / therapeutic use
|
| 653 |
|
|
|a Instillation, Drug
|
| 653 |
|
|
|a Acetylcysteine / therapeutic use
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Practice Guidelines as Topic
|
| 653 |
|
|
|a Mucus
|
| 700 |
1 |
|
|a McCormack, Suzanne
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK549208
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of the current report is to evaluate the clinical effectiveness and evidence-based guidelines regarding NAC instillation during bronchoscopy for non-cystic fibrosis patients requiring mucus secretion clearance. The findings of this review are complimented by two additional reports on the use of NAC in patients requiring mucus secretion clearance (not specific to bronchoscopy), conducted separately by CADTH.
|